161 Probiogen introduces novel productivity-boosting technology for therapeutic protein production: pathway modulator B3C newswire, June 15, 2012
162 Malaria intervention policies and pharmaceutical nanotechnology as a potential tool for malaria management Drug Development Research, June 7, 2012
163 Immunogen, inc. announces presentation of new clinical data for sar3419 Full Text ImmunoGen, Inc., June 5, 2012
164 Sanofi inaugurates lantus solostar pen assembly plant in its beijing facility Full Text Sanofi, May 30, 2012
165 Data Cleansing is a Life Saver Health Data Management, May 22, 2012
166 U.S. FDA approves bristol-myers squibb devens biologics manufacturing facility for production of orencia (abatacept) Full Text Bristol Myers-Squibb, May 16, 2012
167 Leading cdmo completes its brand new center for visual inspection and logistics B3C newswire, May 14, 2012
168 Polish Bid For Biotech Glory Pharmaceutical Executive Magazine, May 10, 2012
169 Bioterrorism: toxins as weapons Journal of Pharmacy Practice, May 10, 2012
170 Optimizing drug delivery for modern biologics Full Text BioPharm International, May 7, 2012
171 Sartorius stedim biotech and c-lecta sign sales agreement B3C newswire, May 4, 2012
172 Nano-advantage in enhanced drug delivery with biodegradable nanoparticles: contribution of reduced clearance Drug Metabolism and Disposition, May 3, 2012
173 Sartorius stedim biotech launches initiative to enhance supply chain security B3C newswire, April 30, 2012
174 Immunogen, inc. reports third quarter fiscal year 2012 financial results and provides quarterly update Full Text ImmunoGen, Inc., April 30, 2012
175 A leading CDMO secures triple-digit million euro credit facility B3C newswire, April 27, 2012
176 Shareholders are investing 8.3 million Euro in the expanding business–Rainer Hepberger new CFO–Phase III study begins for ICES13 B3C newswire, April 27, 2012
177 Significant improvement in disability scores observed in multiple sclerosis patients who received lemtrada (alemtuzumab) compared with rebif in phase lll trial Full Text Sanofi, April 26, 2012
178 Immunogen, inc. announces the ind is now active for its folate-receptor targeting anticancer compound, imgn853 Full Text ImmunoGen, Inc., April 18, 2012
179 Trends in oral drug bioavailability following bariatric surgery: Examining the variable extent of impact on exposure of different drug classes British Journal of Clinical Pharmacology, April 12, 2012
180 A strong start to 2012 Full Text BioPharm International, April 9, 2012
1 More than 900 Biologics in Development BioPharm International, March 22, 2013 Free full text
2 Biologics Research Promises to Bolster Future of Medicine PhRMA, March 12, 2013 Free full text
3 High Availability and Unified Data Management in a High-Demand Environment Healthcare Informatics, April 22, 2013 Free full text
4 With the help of a foreign ally: biopharmaceutical innovation in India after TRIPS Health Policy and Planning, April 8, 2013 Review Article
5 Emerging Outsourcing Trends in 2013 BioPharm International, April 3, 2013 Free full text
6 Multifunctional nanocarriers Advanced Drug Delivery Reviews, February 14, 2013 Review Article
7 Revolutionary Autoinjector Pushes the Limits of High Viscosity Drug Delivery B3C newswire, April 19, 2013 Free full text
8 BioRad - A Purification Strategy for Clinical-Grade Monoclonal Antibody Using Hydrophobic Cation Exchange Chromatography BioPharm International, February 26, 2013 Free full text
9 HIMSS to Build Innovation Center Health Data Management, April 1, 2013 Free full text
10 Abbott to Collaborate with Janssen and Pharmacyclics on Development of Companion Test for Investigational Leukemia Therapy Abbott, February 22, 2013
11 Biogen Acquires Full Tysabri Rights from Elan BioPharm International, February 15, 2013 Free full text
12 Teva and Lonza Review Biosimilars Opportunity BioPharm International, April 9, 2013 Free full text
13 XenoPort Provides Update on Its Introduction of Horizant XenoPort, April 15, 2013 Free full text
Indexed Journals in Pharma News: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close